» Articles » PMID: 22862945

Regulation of Hematopoietic Stem and Progenitor Cell Mobilization by Cholesterol Efflux Pathways

Overview
Journal Cell Stem Cell
Publisher Cell Press
Specialty Cell Biology
Date 2012 Aug 7
PMID 22862945
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Intact cholesterol homeostasis helps to maintain hematopoietic stem and multipotential progenitor cell (HSPC) quiescence. Mice with defects in cholesterol efflux pathways due to deficiencies of the ATP binding cassette transporters ABCA1 and ABCG1 displayed a dramatic increase in HSPC mobilization and extramedullary hematopoiesis. Increased extramedullary hematopoiesis was associated with elevated serum levels of G-CSF due to generation of IL-23 by splenic macrophages and dendritic cells. This favored hematopoietic lineage decisions toward granulocytes rather than macrophages in the bone marrow leading to impaired support for osteoblasts and decreased Cxcl12/SDF-1 production by mesenchymal progenitors. Greater HSPC mobilization and extramedullary hematopoiesis were reversed by raising HDL levels in Abca1(-/-)Abcg1(-/-) and Apoe(-/-) mice or in a mouse model of myeloproliferative neoplasm mediated by Flt3-ITD mutation. Our data identify a role of cholesterol efflux pathways in the control of HSPC mobilization. This may translate into therapeutic strategies for atherosclerosis and hematologic malignancies.

Citing Articles

Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic Potential.

Kohutek Z, Caslin H, Fehrenbach D, Heimlich J, Brown J, Madhur M Circ Res. 2025; 136(3):325-353.

PMID: 39883790 PMC: 11790260. DOI: 10.1161/CIRCRESAHA.124.323778.


The spleen in ischaemic heart disease.

Heusch G, Kleinbongard P Nat Rev Cardiol. 2025; .

PMID: 39743566 DOI: 10.1038/s41569-024-01114-x.


Haematometabolism rewiring in atherosclerotic cardiovascular disease.

Yvan-Charvet L, Barouillet T, Borowczyk C Nat Rev Cardiol. 2025; .

PMID: 39743562 DOI: 10.1038/s41569-024-01108-9.


Mitigating Vascular Inflammation by Mimicking AIBP Mechanisms: A New Therapeutic End for Atherosclerotic Cardiovascular Disease.

Kim J, Jain A, Fang L Int J Mol Sci. 2024; 25(19).

PMID: 39408645 PMC: 11477018. DOI: 10.3390/ijms251910314.


Lipoprotein metabolism mediates hematopoietic stem cell responses under acute anemic conditions.

Saito K, van der Garde M, Umemoto T, Miharada N, Sjoberg J, Sigurdsson V Nat Commun. 2024; 15(1):8131.

PMID: 39284836 PMC: 11405780. DOI: 10.1038/s41467-024-52509-w.


References
1.
Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N . Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol. 2005; 6(10):1038-46. DOI: 10.1038/ni1251. View

2.
Gourion-Arsiquaud S, Allen M, Burr D, Vashishth D, Tang S, Boskey A . Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone. 2009; 46(3):666-72. PMC: 2823979. DOI: 10.1016/j.bone.2009.11.011. View

3.
Levesque J, Hendy J, Takamatsu Y, Simmons P, Bendall L . Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003; 111(2):187-96. PMC: 151860. DOI: 10.1172/JCI15994. View

4.
Winkler I, Sims N, Pettit A, Barbier V, Nowlan B, Helwani F . Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood. 2010; 116(23):4815-28. DOI: 10.1182/blood-2009-11-253534. View

5.
Zhang J, Niu C, Ye L, Huang H, He X, Tong W . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-41. DOI: 10.1038/nature02041. View